Please assess the completion status of the following clinical trial:

Trial Title: Telephone Support to Improve Adherence to Anti-HIV Medications

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Enrollment in an AIDS Clinical Trials Group (ACTG) treatment study that is an approved A5251 parent or coenrolling partner study (ACTG parent study participant) or not enrolled in one of the ACTG parent studies, but receiving routine HIV patient care at an institution that was also an ACTG-funded site (ACTG clinic patient participant).~* Virologic failure on combination antiretroviral therapy (ART), with an HIV-1 genotype conducted on or soon after the failure, within 16 weeks prior to entry. Availability of HIV-1 genotype results at entry.~* History of prior nonadherence to ART during the past year documented either by patient self-report or recorded in the patient's medical record~* Most recent HIV-1 RNA value of at least 200 copies/mL, obtained within 90 days prior to study entry and measured using any FDA-approved test for quantifying HIV-1 RNA~* Initiating or restarting an ART regimen with 2 or more active ARV medications within 3 days after randomization. The regimen must have been selected for the participant prior to the time of randomization for A5251. An active ARV medication was defined as a medication to which the participant was expected to be susceptible based on HIV-1 resistance testing, as specified in the ACTG parent study, or determined by the participant's health care provider per standard of care.~Exclusion Criteria:~* No regular access to a phone. Candidates without phones may have elected to participate by calling the HIV nurse specialists using an 800 number, rather than being called by the HIV nurse specialist.~* Coenrollment in another adherence trial, unless approved by the A5251 study chair~* Current incarceration~* Any condition that, in the opinion of the site investigator, would have compromised the candidate's ability to participate in the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Enhanced nursing telephone support with standard care (Type: EXPERIMENTAL): Participants received enhanced nursing telephone support plus care as usual.
- Standard care (Type: ACTIVE_COMPARATOR): Participants received care as usual.

Based on this trial design, predict the completion outcome and termination type (if applicable).